118 related articles for article (PubMed ID: 36057223)
1. Tannins in Terminalia bellirica inhibits hepatocellular carcinoma growth via re-educating tumor-associated macrophages and restoring CD8
Chang Z; Zhang Q; Hu Q; Liu Y; Zhang L; Liu R
Biomed Pharmacother; 2022 Oct; 154():113543. PubMed ID: 36057223
[TBL] [Abstract][Full Text] [Related]
2. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
3. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
4. Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma.
Song Z; Wang X; Liu X; Luo Y; Qiu J; Yin A; Liu Y; Yi H; Xiao Z; Li A
Biochem Pharmacol; 2023 Jul; 213():115612. PubMed ID: 37209858
[TBL] [Abstract][Full Text] [Related]
5. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression.
Li Y; Chen Y; Zhao C; Yang Y; Zhang M; Cheng H; Li Q; Wang M
Phytomedicine; 2024 Jun; 128():155532. PubMed ID: 38493722
[TBL] [Abstract][Full Text] [Related]
6. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
[TBL] [Abstract][Full Text] [Related]
7. YAP/STAT3 inhibited CD8
Wang C; Shen N; Guo Q; Tan X; He S
Cancer Med; 2023 Aug; 12(15):16295-16309. PubMed ID: 37329188
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
10. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling.
Zhang X; Lu X; Shi J; Li Y; Li Y; Tao R; Huang L; Tang Y; Zhu X; Li M; Gao Y; Feng H; Yu Z
Phytomedicine; 2024 Apr; 126():155395. PubMed ID: 38340578
[TBL] [Abstract][Full Text] [Related]
11. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
Yang LF; Zhang ZB; Wang L
Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
[TBL] [Abstract][Full Text] [Related]
12. Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization.
Wang M; Li Y; Li S; Wang T; Wang M; Wu H; Zhang M; Luo S; Zhao C; Li Q; Cheng H
J Ethnopharmacol; 2024 Mar; 321():117472. PubMed ID: 37995825
[TBL] [Abstract][Full Text] [Related]
13. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma.
Han S; Bao X; Zou Y; Wang L; Li Y; Yang L; Liao A; Zhang X; Jiang X; Liang D; Dai Y; Zheng QC; Yu Z; Guo J
Sci Adv; 2023 Jul; 9(29):eadg2697. PubMed ID: 37467325
[TBL] [Abstract][Full Text] [Related]
14. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
15. Increased OIT3 in macrophages promotes PD-L1 expression and hepatocellular carcinogenesis via NF-κB signaling.
Wen J; Yang S; Yan G; Lei J; Liu X; Zhang N; Zhang J; Deng H; Wu L; Li Y
Exp Cell Res; 2023 Jul; 428(2):113651. PubMed ID: 37201744
[TBL] [Abstract][Full Text] [Related]
16. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell SPTBN1 inhibits M2 polarization of macrophages by suppressing CXCL1 expression.
Wu H; Jiang N; Li J; Jin Q; Jin J; Guo J; Wei X; Wang X; Yao L; Meng D; Zhi X
J Cell Physiol; 2024 Jan; 239(1):97-111. PubMed ID: 37921259
[TBL] [Abstract][Full Text] [Related]
18. Supramolecular Polymer-Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage-Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti-Angiogenesis Therapy of Orthotopic Hepatocellular Carcinoma.
Liu X; Huangfu Y; Wang J; Kong P; Tian W; Liu P; Fang C; Li S; Nie Y; Feng Z; Huang P; Shi S; Zhang C; Dong A; Wang W
Adv Sci (Weinh); 2023 Aug; 10(22):e2300637. PubMed ID: 37229748
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma.
Chen F; Yang L; Peng X; Mao M; Liu X; Song J; Hu J
Mol Immunol; 2022 Nov; 151():204-217. PubMed ID: 36179603
[TBL] [Abstract][Full Text] [Related]
20. Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8
Zhang X; Wei Z; Yong T; Li S; Bie N; Li J; Li X; Liu H; Xu H; Yan Y; Zhang B; Chen X; Yang X; Gan L
Nat Commun; 2023 Sep; 14(1):5653. PubMed ID: 37704614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]